Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Revenue

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹141 Cr₹115 Cr₹11,271,608 Cr₹126 Cr₹123 Cr

What is the latest Revenue of MEDICAMEN BIOTECH ?

The latest Revenue ratio of MEDICAMEN BIOTECH is ₹141 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹141 Cr
Mar2023₹115 Cr
Mar2022₹11,271,608 Cr
Mar2021₹126 Cr
Mar2020₹123 Cr

How is Revenue of MEDICAMEN BIOTECH Trending?

Years Revenue % Change
Mar2024 ₹141 Cr
22.02
Mar2023 ₹115 Cr
-100.00
Mar2022 ₹11,271,608 Cr
8,980,974.92
Mar2021 ₹126 Cr
2.37
Mar2020 ₹123 Cr -

Compare Revenue of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹546.9 Cr -13.3% -10% -10.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
CIPLA ₹117,835.0 Cr 0.1% 1.2% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,784.6 Cr -2.1% -8.7% -2.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-13.3%

-10%

-10.2%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses